{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:04:44Z","timestamp":1789661084831,"version":"4.0.1"},"reference-count":129,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007505","name":"Kirsten and Freddy Johansens Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002808","name":"Carlsberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Spain Ministry of Science Innovation and Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Generalitat de Catalunya Agencia de Gestio d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008738","name":"Jeansson Foundations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"EFSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Swedish Society for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.chembiol.2026.06.003","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:59:24Z","timestamp":1783522764000},"page":"1284-1299.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways"],"prefix":"10.1016","volume":"33","author":[{"given":"Peter","family":"Lindquist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk R.","family":"Hoegen Dijkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.","family":"Drzazga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz M.","family":"Stepniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Granlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maico Y.","family":"Lechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e6rke S.","family":"Gasbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolette","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker M.","family":"Lauschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J.","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper V.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Korsgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Selent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9600-3254","authenticated-orcid":false,"given":"Mette M.","family":"Rosenkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2026.06.003_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants","volume":"387","author":"Collaboration","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.chembiol.2026.06.003_bib2","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s42255-024-01113-9","article-title":"GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management","volume":"6","author":"Holst","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib3","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0140-6736(24)01210-8","article-title":"Obesity in adults","volume":"404","author":"Lingvay","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.chembiol.2026.06.003_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.metabol.2019.04.014","article-title":"The incretin system in healthy humans: The role of GIP and GLP-1","volume":"96","author":"Holst","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.chembiol.2026.06.003_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","article-title":"Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus","volume":"91","author":"Nauck","year":"1993","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.chembiol.2026.06.003_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","article-title":"GLP-1-based therapies for diabetes, obesity and beyond","volume":"24","author":"Drucker","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.chembiol.2026.06.003_bib7","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","article-title":"Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule","volume":"36","author":"Ben Nasr","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.chembiol.2026.06.003_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1099451","article-title":"Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)","volume":"13","author":"Berra","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib10","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.2337\/dc25-0472","article-title":"Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis","volume":"48","author":"Rossing","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.chembiol.2026.06.003_bib11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2410819","article-title":"Tirzepatide for Obesity Treatment and Diabetes Prevention","volume":"392","author":"Jastreboff","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chembiol.2026.06.003_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s42255-023-00966-w","article-title":"A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings","volume":"6","author":"V\u00e9niant","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMoa2504214","article-title":"Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial","volume":"393","author":"Jastreboff","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chembiol.2026.06.003_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41574-023-00938-w","article-title":"Advances in incretin-based therapeutics for obesity","volume":"20","author":"Rosenkilde","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/35067575","article-title":"Oligomerization of G-protein-coupled transmitter receptors","volume":"2","author":"Bouvier","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.chembiol.2026.06.003_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2025.108829","article-title":"Receptor dimers and biased ligands: Novel strategies for targeting G protein-coupled receptors","volume":"269","author":"Liu","year":"2025","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.chembiol.2026.06.003_bib17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ceb.2018.10.007","article-title":"GPCR homo-oligomerization","volume":"57","author":"Milligan","year":"2019","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib18","doi-asserted-by":"crossref","first-page":"18607","DOI":"10.1073\/pnas.1205227109","article-title":"Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery","volume":"109","author":"Harikumar","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2026.06.003_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1210\/en.2017-00023","article-title":"Coexpressed Class B G Protein-Coupled Secretin and GLP-1 Receptors Self- and Cross-Associate: Impact on Pancreatic Islets","volume":"158","author":"Harikumar","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.chembiol.2026.06.003_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12031-008-9060-z","article-title":"Pattern of intra-family hetero-oligomerization involving the G-protein-coupled secretin receptor","volume":"36","author":"Harikumar","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.chembiol.2026.06.003_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.regpep.2010.06.001","article-title":"Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization","volume":"164","author":"Harikumar","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.chembiol.2026.06.003_bib22","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/s41401-021-00758-6","article-title":"Signaling profiles in HEK 293T cells co-expressing GLP-1 and GIP receptors","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.chembiol.2026.06.003_bib23","article-title":"GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys","volume":"2","author":"Lu","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.chembiol.2026.06.003_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41589-024-01714-1","article-title":"Endogenous cell membrane interactome mapping for the GLP-1 receptor in different cell types","volume":"21","author":"Dang","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1124\/mol.111.074757","article-title":"Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation","volume":"81","author":"Schelshorn","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1013","article-title":"Differential effects of glucose-dependent insulinotropic polypeptide receptor\/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells","volume":"10","author":"Al-Zaid","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.chembiol.2026.06.003_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032675","article-title":"Regulation of GIP and GLP1 receptor cell surface expression by N-glycosylation and receptor heteromerization","volume":"7","author":"Whitaker","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2026.06.003_bib28","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferr\u00e9","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.chembiol.2026.06.003_bib29","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chembiol.2026.06.003_bib30","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1042\/BCJ20170184","article-title":"Spatial intensity distribution analysis quantifies the extent and regulation of homodimerization of the secretin receptor","volume":"474","author":"Ward","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.chembiol.2026.06.003_bib31","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1038\/s41467-023-41893-4","article-title":"GLP-1R signaling neighborhoods associate with the susceptibility to adverse drug reactions of incretin mimetics","volume":"14","author":"Wright","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.06.003_bib32","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/jamia\/ocv153","article-title":"OpenFDA: an innovative platform providing access to a wealth of FDA's publicly available data","volume":"23","author":"Kass-Hout","year":"2016","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"10.1016\/j.chembiol.2026.06.003_bib33","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/j.1460-2075.1992.tb05426.x","article-title":"Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation","volume":"11","author":"Backer","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2026.06.003_bib34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1006\/bbrc.1998.9906","article-title":"Expression of adenylyl cyclase subtypes in pancreatic beta-cells","volume":"254","author":"Leech","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chembiol.2026.06.003_bib35","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1074\/jbc.274.4.2000","article-title":"Glucose decreases Na+,K+-ATPase activity in pancreatic beta-cells. An effect mediated via Ca2+-independent phospholipase A2 and protein kinase C-dependent phosphorylation of the alpha-subunit","volume":"274","author":"Owada","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2026.06.003_bib36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.semnephrol.2005.03.004","article-title":"Na,K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation","volume":"25","author":"Blanco","year":"2005","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib37","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/ijc.24748","article-title":"Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt","volume":"125","author":"Bai","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.chembiol.2026.06.003_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2005.09.006","article-title":"The BAD protein integrates survival signaling by EGFR\/MAPK and PI3K\/Akt kinase pathways in PTEN-deficient tumor cells","volume":"8","author":"She","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.chembiol.2026.06.003_bib39","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ajhg.2020.04.018","article-title":"Loss of Function of RIMS2 Causes a Syndromic Congenital Cone-Rod Synaptic Disease with Neurodevelopmental and Pancreatic Involvement","volume":"106","author":"Mechaussier","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.chembiol.2026.06.003_bib40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/gene.2008.12","article-title":"The association between type 1 diabetes and the ITPR3 gene polymorphism due to linkage disequilibrium with HLA class II","volume":"9","author":"Qu","year":"2008","journal-title":"Genes Immun."},{"key":"10.1016\/j.chembiol.2026.06.003_bib41","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00125-017-4524-8","article-title":"Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets","volume":"61","author":"Llacua","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.chembiol.2026.06.003_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108159","article-title":"Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells","volume":"36","author":"Wang","year":"2022","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.chembiol.2026.06.003_bib43","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.chembiol.2026.06.003_bib44","doi-asserted-by":"crossref","first-page":"15475","DOI":"10.1073\/pnas.95.26.15475","article-title":"Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins","volume":"95","author":"Hayward","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2026.06.003_bib45","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.2337\/db13-1607","article-title":"ADCY5 couples glucose to insulin secretion in human islets","volume":"63","author":"Hodson","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.chembiol.2026.06.003_bib46","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/emboj\/16.8.1909","article-title":"Mitogen-activated protein kinases activate the serine\/threonine kinases Mnk1 and Mnk2","volume":"16","author":"Waskiewicz","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.chembiol.2026.06.003_bib47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cbic.201600541","article-title":"SHIP2: Structure, Function and Inhibition","volume":"18","author":"Thomas","year":"2017","journal-title":"Chembiochem"},{"key":"10.1016\/j.chembiol.2026.06.003_bib48","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1038\/s41467-018-06136-x","article-title":"Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations","volume":"9","author":"Chang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.06.003_bib49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.phrs.2017.02.004","article-title":"ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease","volume":"119","author":"Watson","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.chembiol.2026.06.003_bib50","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.febslet.2005.12.070","article-title":"Cyclin D1 activation through ATF-2 in Reg-induced pancreatic beta-cell regeneration","volume":"580","author":"Takasawa","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chembiol.2026.06.003_bib51","doi-asserted-by":"crossref","first-page":"12361","DOI":"10.1074\/jbc.M213069200","article-title":"Akt activation promotes degradation of tuberin and FOXO3a via the proteasome","volume":"278","author":"Plas","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2026.06.003_bib52","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/febs.17338","article-title":"Arrestin-independent internalization of the GLP-1 receptor is facilitated by a GRK, clathrin, and caveolae-dependent mechanism","volume":"292","author":"Moo","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.chembiol.2026.06.003_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116119","article-title":"The role of G protein-coupled receptor kinases in GLP-1R beta-arrestin recruitment and internalisation","volume":"222","author":"McNeill","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib54","doi-asserted-by":"crossref","first-page":"43282","DOI":"10.1074\/jbc.M111.256909","article-title":"Helix 8 plays a crucial role in bradykinin B(2) receptor trafficking and signaling","volume":"286","author":"Feierler","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2026.06.003_bib55","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/mol.109.059733","article-title":"Role of helix 8 of the thyrotropin-releasing hormone receptor in phosphorylation by G protein-coupled receptor kinase","volume":"77","author":"Gehret","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib56","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/cr.2017.72","article-title":"Molecular assembly of rhodopsin with G protein-coupled receptor kinases","volume":"27","author":"He","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.chembiol.2026.06.003_bib57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cell.2017.03.047","article-title":"Structural and Functional Analysis of a beta(2)-Adrenergic Receptor Complex with GRK5","volume":"169","author":"Komolov","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2026.06.003_bib58","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-021-03721-x","article-title":"Structures of rhodopsin in complex with G-protein-coupled receptor kinase 1","volume":"595","author":"Chen","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2026.06.003_bib59","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-023-06395-9","article-title":"GPCR activation and GRK2 assembly by a biased intracellular agonist","volume":"620","author":"Duan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2026.06.003_bib60","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/s42255-024-01061-4","article-title":"Characterization of genetic variants of GIPR reveals a contribution of beta-arrestin to metabolic phenotypes","volume":"6","author":"Kizilkaya","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101181","article-title":"Spatiotemporal GLP-1 and GIP receptor signaling and trafficking\/recycling dynamics induced by selected receptor mono- and dual-agonists","volume":"49","author":"Novikoff","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib62","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/acsptsci.0c00193","article-title":"GLP-1 Val8: A Biased GLP-1R Agonist with Altered Binding Kinetics and Impaired Release of Pancreatic Hormones in Rats","volume":"4","author":"van der Velden","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.chembiol.2026.06.003_bib63","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/bcpt.13289","article-title":"Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long-term impairment of the GIP system","volume":"126","author":"Gabe","year":"2020","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106890","article-title":"The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively","volume":"9","author":"Al-Sabah","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2026.06.003_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116893","article-title":"Development of a long-acting unbiased GIP receptor agonist for studies of GIP's role in bone metabolism","volume":"236","author":"Tordrup","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib66","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcp.2018.01.040","article-title":"Human GIP(3-30)NH(2) inhibits G protein-dependent as well as G protein-independent signaling and is selective for the GIP receptor with high-affinity binding to primate but not rodent GIP receptors","volume":"150","author":"Gabe","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib67","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1074\/jbc.M114.592436","article-title":"Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking","volume":"290","author":"Roed","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2026.06.003_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba2083","article-title":"PhenomeXcan: Mapping the genome to the phenome through the transcriptome","volume":"6","author":"Pividori","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.chembiol.2026.06.003_bib69","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fendo.2015.00010","article-title":"Oligomerization of Family B GPCRs: Exploration in Inter-Family Oligomer Formation","volume":"6","author":"Ng","year":"2015","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib70","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","article-title":"Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes","volume":"117","author":"Nielsen","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.chembiol.2026.06.003_bib71","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.mce.2013.11.010","article-title":"Real-time trafficking and signaling of the glucagon-like peptide-1 receptor","volume":"382","author":"Roed","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib72","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00125-005-0128-9","article-title":"Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs","volume":"49","author":"Simonsen","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.chembiol.2026.06.003_bib73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.regpep.2012.12.012","article-title":"The C-terminal extension of exendin-4 provides additional metabolic stability when added to GLP-1, while there is minimal effect of truncating exendin-4 in anaesthetized pigs","volume":"181","author":"Simonsen","year":"2013","journal-title":"Regul. Pept."},{"key":"10.1016\/j.chembiol.2026.06.003_bib74","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","article-title":"Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction","volume":"21","author":"Nauck","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib75","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1074\/jbc.M117.779496","article-title":"Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R)","volume":"292","author":"Koole","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2026.06.003_bib76","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.bbamem.2008.07.008","article-title":"Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor","volume":"1778","author":"Harikumar","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chembiol.2026.06.003_bib77","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1096\/fj.201902007R","article-title":"Dimerization\/oligomerization of the extracellular domain of the GLP-1 receptor and the negative cooperativity in its ligand binding revealed by the improved NanoBiT","volume":"34","author":"Song","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.chembiol.2026.06.003_bib78","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1038\/s41467-024-48853-6","article-title":"Impact of secretin receptor homo-dimerization on natural ligand binding","volume":"15","author":"Harikumar","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.06.003_bib79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.coph.2009.10.009","article-title":"Functional crosstalk between GPCRs: with or without oligomerization","volume":"10","author":"Prezeau","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib80","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.016334","article-title":"Genetic and biased agonist-mediated reductions in beta-arrestin recruitment prolong cAMP signaling at glucagon family receptors","volume":"296","author":"Jones","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2026.06.003_bib81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tips.2008.02.004","article-title":"How and why do GPCRs dimerize?","volume":"29","author":"Gurevich","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.chembiol.2026.06.003_bib82","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41467-017-00253-9","article-title":"Agonist-induced dimer dissociation as a macromolecular step in G protein-coupled receptor signaling","volume":"8","author":"Petersen","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.06.003_bib83","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41467-018-03941-2","article-title":"Targeting GLP-1 receptor trafficking to improve agonist efficacy","volume":"9","author":"Jones","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.06.003_bib84","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/dom.15288","article-title":"Abolishing beta-arrestin recruitment is necessary for the full metabolic benefits of G protein-biased glucagon-like peptide-1 receptor agonists","volume":"26","author":"Hinds","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119584","article-title":"Characterization of the real-time internalization of nine GPCRs reveals distinct dependence on arrestins and G proteins","volume":"1871","author":"M\u00f8ller","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.chembiol.2026.06.003_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.embor.7400052","article-title":"Roles of G-protein-coupled receptor dimerization","volume":"5","author":"Terrillon","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.chembiol.2026.06.003_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101139","article-title":"Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms","volume":"46","author":"Campbell","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib88","doi-asserted-by":"crossref","first-page":"E931","DOI":"10.1152\/ajpendo.00270.2002","article-title":"Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis","volume":"284","author":"Pamir","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib89","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2337\/diabetes.47.7.1046","article-title":"Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -\/- mice","volume":"47","author":"Pederson","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.chembiol.2026.06.003_bib90","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmet.2018.12.001","article-title":"Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism","volume":"20","author":"Mroz","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib91","doi-asserted-by":"crossref","first-page":"E435","DOI":"10.1152\/ajpendo.00437.2024","article-title":"Single incretin receptor knockout mice do not compensate by increasing glucose-stimulated secretion of the remaining incretin hormone","volume":"328","author":"Galsgaard","year":"2025","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib92","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s42255-025-01294-x","article-title":"GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice","volume":"7","author":"Gutgesell","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib93","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41586-024-08504-8","article-title":"A comprehensive spatio-cellular map of the human hypothalamus","volume":"639","author":"Tadross","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2026.06.003_bib94","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1111\/bph.16478","article-title":"Altered desensitization and internalization patterns of rodent versus human glucose-dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge","volume":"182","author":"Gasbjerg","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171212","article-title":"GIP-derived GIP receptor antagonists - a review of their role in GIP receptor pharmacology","volume":"177","author":"Rosenkilde","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/j.chembiol.2026.06.003_bib96","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bph.13323","article-title":"Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors","volume":"173","author":"Sparre-Ulrich","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib97","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41588-017-0011-x","article-title":"Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity","volume":"50","author":"Turcot","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2026.06.003_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.749607","article-title":"Loss of Function Glucose-Dependent Insulinotropic Polypeptide Receptor Variants Are Associated With Alterations in BMI, Bone Strength and Cardiovascular Outcomes","volume":"9","author":"Kizilkaya","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib99","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.chembiol.2026.06.003_bib100","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00125-002-0878-6","article-title":"Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients","volume":"45","author":"Vilsboll","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.chembiol.2026.06.003_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102118","article-title":"Glucose-dependent insulinotropic polypeptide (GIP)","volume":"95","author":"M\u00fcller","year":"2025","journal-title":"Mol. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib102","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s42255-023-00889-6","article-title":"Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity","volume":"5","author":"Gao","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib103","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/s41588-023-01462-3","article-title":"GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification","volume":"55","author":"Lagou","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2026.06.003_bib104","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad028","article-title":"Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells","volume":"164","author":"Manchanda","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.chembiol.2026.06.003_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102094","article-title":"Chronic GIPR agonism results in pancreatic islet GIPR functional desensitisation","volume":"92","author":"Davies","year":"2025","journal-title":"Mol. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib106","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-020-18751-8","article-title":"Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism","volume":"11","author":"Killion","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.06.003_bib107","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide Once Weekly for the Treatment of Obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chembiol.2026.06.003_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102006","article-title":"AT-7687, a novel GIPR peptide antagonist, combined with a GLP-1 agonist, leads to enhanced weight loss and metabolic improvements in cynomolgus monkeys","volume":"88","author":"Jensen","year":"2024","journal-title":"Mol. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib109","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chembiol.2026.06.003_bib110","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41594-022-00797-5","article-title":"Structural insight into apelin receptor-G protein stoichiometry","volume":"29","author":"Yue","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib111","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aal3395","article-title":"Genetic evidence that beta-arrestins are dispensable for the initiation of beta(2)-adrenergic receptor signaling to ERK","volume":"10","author":"O\u2019Hayre","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.chembiol.2026.06.003_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101413","article-title":"Molecular and in vivo phenotyping of missense variants of the human glucagon receptor","volume":"298","author":"van der Velden","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2026.06.003_bib113","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1111\/bph.15866","article-title":"N-terminal alterations turn the gut hormone GLP-2 into an antagonist with gradual loss of GLP-2 receptor selectivity towards more GLP-1 receptor interaction","volume":"179","author":"Gabe","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib114","doi-asserted-by":"crossref","first-page":"17337","DOI":"10.1074\/jbc.M512510200","article-title":"Metal ion site engineering indicates a global toggle switch model for seven-transmembrane receptor activation","volume":"281","author":"Elling","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2026.06.003_bib115","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1074\/jbc.RA118.001975","article-title":"Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells","volume":"293","author":"Wan","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chembiol.2026.06.003_bib116","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41467-022-28056-7","article-title":"Heterotrimeric Gq proteins act as a switch for GRK5\/6 selectivity underlying beta-arrestin transducer bias","volume":"13","author":"Kawakami","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.06.003_bib117","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf186","article-title":"Deep learning in GPCR drug discovery: benchmarking the path to accurate peptide binding","volume":"26","author":"Hoegen Dijkhof","year":"2025","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.chembiol.2026.06.003_bib118","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/bioinformatics\/btz502","article-title":"iCn3D, a web-based 3D viewer for sharing 1D\/2D\/3D representations of biomolecular structures","volume":"36","author":"Wang","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.chembiol.2026.06.003_bib119","doi-asserted-by":"crossref","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib120","doi-asserted-by":"crossref","first-page":"W307","DOI":"10.1093\/nar\/gkx336","article-title":"BIS2Analyzer: a server for co-evolution analysis of conserved protein families","volume":"45","author":"Oteri","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2026.06.003_bib121","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41586-022-05575-3","article-title":"An atlas of substrate specificities for the human serine\/threonine kinome","volume":"613","author":"Johnson","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2026.06.003_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101772","article-title":"EndoC-betaH5 cells are storable and ready-to-use human pancreatic beta cells with physiological insulin secretion","volume":"76","author":"Blanchi","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.chembiol.2026.06.003_bib123","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molcel.2020.09.020","article-title":"Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists","volume":"80","author":"Zhang","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.chembiol.2026.06.003_bib124","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41589-021-00945-w","article-title":"Structural and functional diversity among agonist-bound states of the GLP-1 receptor","volume":"18","author":"Cary","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2026.06.003_bib125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM Simulations Using the CHARMM36 Additive Force Field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.chembiol.2026.06.003_bib126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2026.06.003_bib127","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41467-018-03621-1","article-title":"Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics","volume":"9","author":"Barbeira","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2026.06.003_bib128","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/10543406.2013.736810","article-title":"Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database","volume":"23","author":"Huang","year":"2013","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.chembiol.2026.06.003_bib129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0165-6147(89)90266-6","article-title":"Calculating receptor number from binding experiments using same compound as radioligand and competitor","volume":"10","author":"DeBlasi","year":"1989","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945626002011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945626002011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:16:33Z","timestamp":1789658193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945626002011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":129,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2451945626002011"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2026.06.003","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2026.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}